Cargando…

PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles

BACKGROUND: Prostate cancer (PCa) with loss of the tumor suppressor gene PTEN has an unfavorable prognosis. DNA methylation profiles associated with PTEN loss may provide further insights into the mechanisms underlying these more aggressive, clinically relevant tumors. METHODS: The cohort included p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geybels, Milan S., Fang, Min, Wright, Jonathan L., Qu, Xiaoyu, Bibikova, Marina, Klotzle, Brandy, Fan, Jian-Bing, Feng, Ziding, Ostrander, Elaine A., Nelson, Peter S., Stanford, Janet L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663600/ https://www.ncbi.nlm.nih.gov/pubmed/29137428 http://dx.doi.org/10.18632/oncotarget.20940

Ejemplares similares

Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
por: Geybels, Milan S., et al.
Publicado: (2016)

Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors
por: Geybels, Milan S., et al.
Publicado: (2015)

Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort
por: Jhun, Min A., et al.
Publicado: (2017)

Gene expression panel predicts metastatic‐lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer
por: Rubicz, Rohina, et al.
Publicado: (2016)

DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs
por: Dai, James Y., et al.
Publicado: (2020)

A five‐CpG DNA methylation score to predict metastatic‐lethal outcomes in men treated with radical prostatectomy for localized prostate cancer
por: Zhao, Shanshan, et al.
Publicado: (2018)

Substantial DNA methylation differences between two major neuronal subtypes in human brain
por: Kozlenkov, Alexey, et al.
Publicado: (2016)

Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites
por: Kozlenkov, Alexey, et al.
Publicado: (2014)

Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics
por: Munchel, Sarah, et al.
Publicado: (2015)

Analytic Validation of a Clinical-Grade PTEN Immunohistochemistry Assay in Prostate Cancer by Comparison to PTEN FISH
por: Lotan, Tamara L., et al.
Publicado: (2016)

Replication of a Genetic Variant for Prostate Cancer-Specific Mortality
por: Penney, Kathryn L., et al.
Publicado: (2015)

Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer
por: Rizzardi, Anthony E., et al.
Publicado: (2016)

Highly Parallel Genome-Wide Expression Analysis of Single Mammalian Cells
por: Fan, Jian-Bing, et al.
Publicado: (2012)

Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes
por: Karyadi, Danielle M., et al.
Publicado: (2016)

Pisces: an accurate and versatile variant caller for somatic and germline next-generation sequencing data
por: Dunn, Tamsen, et al.
Publicado: (2019)

Correction: Highly Parallel Genome-Wide Expression Analysis of Single Mammalian Cells
por: Fan, Jian-Bing, et al.
Publicado: (2012)

Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study
por: Wright, Jonathan L., et al.
Publicado: (2009)

The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
por: Turnham, Daniel J., et al.
Publicado: (2020)

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases
por: FitzGerald, L. M., et al.
Publicado: (2018)

Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports
por: Xie, Haijie, et al.
Publicado: (2017)

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
por: Lotan, Tamara L., et al.
Publicado: (2017)

Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer
por: Decker, Brennan, et al.
Publicado: (2014)

Gene expression profiling of human whole blood samples with the Illumina WG-DASL assay
por: Winn, Mary E, et al.
Publicado: (2011)

Investigation of PTEN promoter methylation in ameloblastoma
por: Lapthanasupkul, Puangwan, et al.
Publicado: (2020)

Genomic Rearrangements of PTEN in Prostate Cancer
por: Phin, Sopheap, et al.
Publicado: (2013)

A Three-Marker FISH Panel Detects More Genetic Aberrations of AR, PTEN and TMPRSS2/ERG in Castration-Resistant or Metastatic Prostate Cancers than in Primary Prostate Tumors
por: Qu, Xiaoyu, et al.
Publicado: (2013)

A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study
por: Heller, Simon R., et al.
Publicado: (2021)

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer
por: Agalliu, I, et al.
Publicado: (2007)

A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
por: Troyer, Dean A, et al.
Publicado: (2015)

PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
por: Choucair, Khalil, et al.
Publicado: (2012)

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
por: Burdelski, Christoph, et al.
Publicado: (2015)

Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer
por: NOH, BYEONG-JOO, et al.
Publicado: (2016)

PTEN Methylation Dependent Sinonasal Mucosal Melanoma
por: Lee, Sang Hee, et al.
Publicado: (2016)

Pten Dose Dictates Cancer Progression in the Prostate
por: Trotman, Lloyd C, et al.
Publicado: (2003)

Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer
por: Kim, Sung Han, et al.
Publicado: (2015)

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
por: Luebke, Andreas M., et al.
Publicado: (2019)

Engineering PTEN-L for Cell-Mediated Delivery
por: Lavictoire, Sylvie J., et al.
Publicado: (2017)

Promoter methylation of PTEN gene in high grade gliomas
por: Lavanya, C, et al.
Publicado: (2014)

PTEN mutation, methylation and expression in breast cancer patients
por: ZHANG, HONG-YAN, et al.
Publicado: (2013)

Broccoli, PTEN deletion and prostate cancer: where is the link?
por: Appendino, Giovanni, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_k21j43j0ll9jauh2rm5m3jmckt